Freedom Investment Management’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-1,975
Closed -$203K 982
2021
Q4
$203K Sell
1,975
-406
-17% -$39K 0.01% 812
2021
Q3
$208K Sell
2,381
-94
-4% -$8.51K 0.02% 759
2021
Q2
$221K Buy
+2,475
New +$209K 0.02% 795
2017
Q4
Sell
-9,760
Closed -$510K 1190
2017
Q3
$510K Sell
9,760
-357
-4% -$19.9K 0.03% 589
2017
Q2
$592K Sell
10,117
-10,110
-50% -$525K 0.03% 496
2017
Q1
$927K Buy
20,227
+943
+5% +$46.9K 0.05% 319
2016
Q4
$1.01M Buy
+19,284
New +$934K 0.06% 240

Other funds holding SYNH

Freedom Investment Management's SYNH Position: Q1 2022 in Review

Freedom Investment Management sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q1 2022, closing a stake of 1,975 shares — an estimated $203K sold.

Freedom Investment Management first reported a position in SYNH in Q4 2016 and held it in 7 quarters. The position peaked at $1.01M in Q4 2016. 366 funds tracked by Wall St. Rank hold SYNH as of Q1 2022.

  • Freedom Investment Management reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q1 2022 after selling out during the quarter.
  • Freedom Investment Management sold 1,975 Syneos Health, Inc. Class A Common Stock shares in Q1 2022, an estimated $203K.
  • Freedom Investment Management first reported a position in Syneos Health, Inc. Class A Common Stock in Q4 2016 and held it in 7 quarters.
  • Freedom Investment Management's Syneos Health, Inc. Class A Common Stock position peaked at $1.01M in Q4 2016.
  • 366 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q1 2022.

Based on Freedom Investment Management's 13F filing for Q1 2022, filed 16 May 2022.